| Dr Ioannis Parastatidis, MD, PHD | |
|
200 S Enota Dr Ne Ste 100, Gainesville, GA 30501-3466 | |
| (770) 534-2020 | |
| (770) 534-8025 |
| Full Name | Dr Ioannis Parastatidis |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 22 Years |
| Location | 200 S Enota Dr Ne Ste 100, Gainesville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578727038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 067025 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
| Habersham County Medical Ctr | Demorest, GA | Hospital |
| Union General Hospital | Blairsville, GA | Hospital |
| Northeast Georgia Medical Center Lumpkin | Dahlonega, GA | Hospital |
| Stephens County Hospital | Toccoa, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Heart Institute Llc | 4183848062 | 102 |
| Northeast Georgia Medical Center, Inc. | 7517953755 | 30 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 2 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 2 days ago
| Entity Name | Northeast Georgia Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720015993 PECOS PAC ID: 7517953755 Enrollment ID: O20040422000903 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 2 days ago
| Entity Name | Georgia Heart Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477976520 PECOS PAC ID: 4183848062 Enrollment ID: O20140616001425 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ioannis Parastatidis, MD, PHD Po Box 742616, Atlanta, GA 30374-2616 Ph: (770) 219-8420 | Dr Ioannis Parastatidis, MD, PHD 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501-3466 Ph: (770) 534-2020 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 2 days ago
James D Jackson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1285 Sims St, Gainesville, GA 30501 Phone: 770-219-8583 | |
Eileen Javellana, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 725 Jesse Jewell Pkwy Se, Gainesville, GA 30501 Phone: 678-207-4373 Fax: 770-533-4727 | |
Dr. Nitya S Chandra, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501 Phone: 770-534-2020 Fax: 770-534-8025 | |
Dr. Lisa Armsrees Gillespie, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-8420 | |
Dr. Noelle Claudine Stanley, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1211 Sherwood Park Dr Ne Ste B, Gainesville, GA 30501 Phone: 770-219-9179 | |
Kedric Naylor, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 Fax: 770-538-7872 | |
Dr. William Nathan Blake, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Ngpg Inpatient Medicine, Gainesville, GA 30501 Phone: 770-219-6000 Fax: 770-219-6021 |